Semler Scientific, Inc. (SMLR) shares plummeted by 5.97% in Friday's pre-market trading session, significantly underperforming the broader market. The steep decline in the healthcare technology firm's stock was primarily attributed to the company's announcement of a $75 million private offering of convertible senior notes, which raised concerns about potential equity dilution.
The company disclosed its intention to offer the convertible notes due 2030 to institutional buyers, with an option to purchase up to an additional $15 million worth of notes. While the final terms are yet to be determined, Semler Scientific stated that it intends to use a portion of the proceeds to fund capped call transactions and for the acquisition of bitcoin, in line with its bitcoin treasury strategy.
Additionally, the company released preliminary fourth-quarter results, showing revenue expectations in the range of $12.1 million to $12.5 million. Although reflecting year-over-year growth, the revenue guidance may have fallen short of some analysts' projections, further exacerbating the negative sentiment surrounding the stock.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。